NovoCure Vs. Equifax Industry Stock Comparison

Sell

43

NVCR
NovoCure

Last Price:

12.87

Seasonality Move:

6.82%

Buy

58

EFX
Equifax

Last Price:

222.10

Seasonality Move:

3.45%

Sell

43

NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $12.74. The Score for NVCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

58

Equifax (EFX) is a Buy

Is Equifax a Buy, Sell or Hold?

The current Equifax [EFX] share price is $220.67. The Score for EFX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $12.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight selling pressure.

EFX Stock Price Chart

What is Equifax's stock price today?

The Equifax share price today is $220.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EFX is experiencing slight selling pressure.

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.52	Sell
Relative Strength Index (14 RSI):	45.65	Sell
Chaikin Money Flow:	-25256	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.19 - 14.55)	Sell
Bollinger Bands (100):	(12.9 - 15.44)	Sell

EFX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-9.5	Sell
Relative Strength Index (14 RSI):	32.85	Sell
Chaikin Money Flow:	-394075	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(223.76 - 257.44)	Sell
Bollinger Bands (100):	(235.19 - 262.33)	Sell

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.36	Buy
20-day SMA:	12.98	Sell
50-day SMA:	14.23	Sell
200-day SMA:	17.26	Sell
8-day EMA:	12.52	Buy
20-day EMA:	12.92	Sell
50-day EMA:	13.7	Sell
200-day EMA:	22.33	Sell

EFX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	223.15	Sell
20-day SMA:	235.64	Sell
50-day SMA:	252.36	Sell
200-day SMA:	221.7	Sell
8-day EMA:	224.26	Sell
20-day EMA:	233.33	Sell
50-day EMA:	243.24	Sell
200-day EMA:	230.59	Sell

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.

Equifax Earnings Growth & EFX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.

NovoCure Technical Analysis

	Apr 18	Apr 19	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30	May 1
	Apr
	18	19	22	23	24	25	26	29	30	01
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Equifax Technical Analysis

	Apr 18	Apr 19	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30	May 1
	Apr
	18	19	22	23	24	25	26	29	30	01
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):